Healthcare

Implantable Medical Devices Market Size is Forecasted to Reach US$ 145.6 billion by 2030

The global implantable medical device market size is forecasted to reach from US$ 90.5 billion in 2021 to US$ 145.6 billion by 2030 and is anticipated to grow at compounded annual growth rate (CAGR) of 7% from 2022 to 2030, as per reports by market research and consulting organization Precedence Research.

The report contains 150+ pages with detailed analysis. The base year for the study has been considered 2021, the historic year 2017 to 2020, the forecast period considered is from 2022 to 2030. The implantable medical device market is analyzed on the basis of value (US$ Million), volume (Unit), and price (US$/Unit). The report offers exclusive insights to help companies make informed decisions to sustain growth through the assessment period.

Download Free Sample Copy with TOC, Graphs & List of Figures @ https://www.precedenceresearch.com/sample/1430

The technological advancements in the healthcare industry has allowed the people to improve their looks and enhance their beauty by implanting medical devices such as dental implants, breast implants, pectoral implants, deltoid implants, and cochlear implants. The rising concerns regarding the aesthetics and physical appearances among the population is another factor that drives the demand for the implantable medical devices. Moreover, the presence of numerous market players and various developmental strategies adopted by them plays a prominent role in influencing the market. Furthermore, the rising number of accident cases in which limbs or organs are damaged is a major factors that may drive the demand for the implantable medical devices across the globe. All these factors are expected to drive the growth of the global implantable medical devices market during the forecast period.

Report Scope of Implantable Medical Devices Market

Report Coverage Details
Market Size in 2021 USD 90.5 Billion
Growth Rate From 2021 to 2030 CAGR of 7%
Largest Market North America
Fastest Growing Market Asia Pacific
Base Year 2021
Forecast Period 2022 to 2030
Segments Covered Product, Biomaterial, Region

Competitive Landscape Analysis:

Some of the leading companies operating in the implantable medical device market are profiled in the market study. The report also underscores winning strategies adopted over the last few years and gauges impact of the same on growth trajectory exhibited by the market over the last few years.

Major companies operating in this report are

  • Abbott Laboratories
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • C. R. Bard, Inc.
  • Cardinal Health, Inc.
  • CONMED Corporation
  • Globus Medical, Inc.
  • Integra Lifesciences Holdings Corporation
  • Johnson & Johnson
  • LivaNova PLC
  • Medtronic plc
  • NuVasive, Inc.
  • Smith & Nephew plc
  • St. Jude Medical, Inc.
  • InstitutStraumann AG

Market Overview

Owing to the increasing number of diseases and disorders there has been an upsurge in the demand for implantable medical devices. These devices serve the purpose of supporting or replacement of any damaged body organs, and enhancing, and treating the functioning of normal body functions. An implantable medical device is one of the important components of patient care.

The growing elderly population is one of the critical elements of globally active implantable medical devices market growth. With age, there is a gradual decline in the functioning of various parts of the human body. Thus, human has to rely on various medical devices for mobility and other assistance. This creates demand for implantable products. Some of the chronic diseases that affect adults include heart disease, arthritis, among others. Osteoarthritis (OA) is one of the most common joint disorders in the United States. Also called degenerative joint disease, it occurs most frequently in the hands, hips, and knees. Thus, with the expanding aging population, the demand for Orthopedic Implants and Reconstructive Joint Replacement is expected to increase in the country. With the rising prevalence of cardiovascular diseases demands for active implantable devices, including cardiovascular implants, is expected to increase, in both developed and developing countries.

The concerns related to the devices such as device failure and network security are likely to hamper the market growth. For instance, the device introduced in the human body may bring out an immune response from the surrounding tissues and resulting performance degradation makes it difficult to use these devices for a long period.

Segments Covered in the Report

By Product Type

  • Cardiovascular Implants
  • Orthopedic Implants
  • Intraocular Lens
  • Spinal Implants
  • Dental Implants
  • Others

By Biomaterial

  • Ceramic
  • Metallic
  • Polymers
  • Natural

Regional Segmentation

– North America (U.S. and Canada)

 – Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)

 – Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)

 – Latin America (Brazil and Rest of Latin America)

– Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)

Why should you invest in this report?

If you are aiming to enter the global implantable medical device market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for implantable medical device are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2022-2030 so that you can plan your strategies to enter this market accordingly.

Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.

Purchase Full Research Report @ https://www.precedenceresearch.com/checkout/1430

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Implantable Medical Devices Market 

5.1. COVID-19 Landscape: Implantable Medical Devices Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Implantable Medical Devices Market, By Product

8.1. Implantable Medical Devices Market, by Product Type, 2021-2030

8.1.1. Cardiovascular Implants

8.1.1.1. Market Revenue and Forecast (2019-2030)

8.1.2. Orthopedic Implants

8.1.2.1. Market Revenue and Forecast (2019-2030)

8.1.3. Intraocular Lens

8.1.3.1. Market Revenue and Forecast (2019-2030)

8.1.4. Spinal Implants

8.1.4.1. Market Revenue and Forecast (2019-2030)

8.1.5. Dental Implants

8.1.5.1. Market Revenue and Forecast (2019-2030)

8.1.6. Others

8.1.6.1. Market Revenue and Forecast (2019-2030)

Chapter 9. Global Implantable Medical Devices Market, By Biomaterial

9.1. Implantable Medical Devices Market, by Biomaterial, 2021-2030

9.1.1. Ceramic

9.1.1.1. Market Revenue and Forecast (2019-2030)

9.1.2. Metallic

9.1.2.1. Market Revenue and Forecast (2019-2030)

9.1.3. Polymers

9.1.3.1. Market Revenue and Forecast (2019-2030)

9.1.4. Natural

9.1.4.1. Market Revenue and Forecast (2019-2030)

Chapter 10. Global Implantable Medical Devices Market, Regional Estimates and Trend Forecast

10.1. North America

10.1.1. Market Revenue and Forecast, by Product (2019-2030)

10.1.2. Market Revenue and Forecast, by Biomaterial (2019-2030)

10.1.3. U.S.

10.1.3.1. Market Revenue and Forecast, by Product (2019-2030)

10.1.3.2. Market Revenue and Forecast, by Biomaterial (2019-2030)

10.1.4. Rest of North America

10.1.4.1. Market Revenue and Forecast, by Product (2019-2030)

10.1.4.2. Market Revenue and Forecast, by Biomaterial (2019-2030)

10.2. Europe

10.2.1. Market Revenue and Forecast, by Product (2019-2030)

10.2.2. Market Revenue and Forecast, by Biomaterial (2019-2030)

10.2.3. UK

10.2.3.1. Market Revenue and Forecast, by Product (2019-2030)

10.2.3.2. Market Revenue and Forecast, by Biomaterial (2019-2030)

10.2.4. Germany

10.2.4.1. Market Revenue and Forecast, by Product (2019-2030)

10.2.4.2. Market Revenue and Forecast, by Biomaterial (2019-2030)

10.2.5. France

10.2.5.1. Market Revenue and Forecast, by Product (2019-2030)

10.2.5.2. Market Revenue and Forecast, by Biomaterial (2019-2030)

10.2.6. Rest of Europe

10.2.6.1. Market Revenue and Forecast, by Product (2019-2030)

10.2.6.2. Market Revenue and Forecast, by Biomaterial (2019-2030)

10.3. APAC

10.3.1. Market Revenue and Forecast, by Product (2019-2030)

10.3.2. Market Revenue and Forecast, by Biomaterial (2019-2030)

10.3.3. India

10.3.3.1. Market Revenue and Forecast, by Product (2019-2030)

10.3.3.2. Market Revenue and Forecast, by Biomaterial (2019-2030)

10.3.4. China

10.3.4.1. Market Revenue and Forecast, by Product (2019-2030)

10.3.4.2. Market Revenue and Forecast, by Biomaterial (2019-2030)

10.3.5. Japan

10.3.5.1. Market Revenue and Forecast, by Product (2019-2030)

10.3.5.2. Market Revenue and Forecast, by Biomaterial (2019-2030)

10.3.6. Rest of APAC

10.3.6.1. Market Revenue and Forecast, by Product (2019-2030)

10.3.6.2. Market Revenue and Forecast, by Biomaterial (2019-2030)

10.4. MEA

10.4.1. Market Revenue and Forecast, by Product (2019-2030)

10.4.2. Market Revenue and Forecast, by Biomaterial (2019-2030)

10.4.3. GCC

10.4.3.1. Market Revenue and Forecast, by Product (2019-2030)

10.4.3.2. Market Revenue and Forecast, by Biomaterial (2019-2030)

10.4.4. North Africa

10.4.4.1. Market Revenue and Forecast, by Product (2019-2030)

10.4.4.2. Market Revenue and Forecast, by Biomaterial (2019-2030)

10.4.5. South Africa

10.4.5.1. Market Revenue and Forecast, by Product (2019-2030)

10.4.5.2. Market Revenue and Forecast, by Biomaterial (2019-2030)

10.4.6. Rest of MEA

10.4.6.1. Market Revenue and Forecast, by Product (2019-2030)

10.4.6.2. Market Revenue and Forecast, by Biomaterial (2019-2030)

10.5. Latin America

10.5.1. Market Revenue and Forecast, by Product (2019-2030)

10.5.2. Market Revenue and Forecast, by Biomaterial (2019-2030)

10.5.3. Brazil

10.5.3.1. Market Revenue and Forecast, by Product (2019-2030)

10.5.3.2. Market Revenue and Forecast, by Biomaterial (2019-2030)

10.5.4. Rest of LATAM

10.5.4.1. Market Revenue and Forecast, by Product (2019-2030)

10.5.4.2. Market Revenue and Forecast, by Biomaterial (2019-2030)

Chapter 11. Company Profiles

11.1. Abbott Laboratories

11.1.1. Company Overview

11.1.2. Product Offerings

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. Biotronik SE & Co. KG

11.2.1. Company Overview

11.2.2. Product Offerings

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. Boston Scientific Corporation

11.3.1. Company Overview

11.3.2. Product Offerings

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. C. R. Bard, Inc.

11.4.1. Company Overview

11.4.2. Product Offerings

11.4.3. Financial Performance

11.4.4. Recent Initiatives

11.5. Cardinal Health, Inc.

11.5.1. Company Overview

11.5.2. Product Offerings

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. CONMED Corporation

11.6.1. Company Overview

11.6.2. Product Offerings

11.6.3. Financial Performance

11.6.4. Recent Initiatives

11.7. Globus Medical, Inc.

11.7.1. Company Overview

11.7.2. Product Offerings

11.7.3. Financial Performance

11.7.4. Recent Initiatives

11.8. Integra Lifesciences Holdings Corporation

11.8.1. Company Overview

11.8.2. Product Offerings

11.8.3. Financial Performance

11.8.4. Recent Initiatives

11.9. Johnson & Johnson

11.9.1. Company Overview

11.9.2. Product Offerings

11.9.3. Financial Performance

11.9.4. Recent Initiatives

11.10. LivaNova PLC

11.10.1. Company Overview

11.10.2. Product Offerings

11.10.3. Financial Performance

11.10.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Purchase Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1430

Contact Us:         

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

More Articles:

Show More

Precedence Research

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.

Related Articles

Back to top button